Digital AI in drug development: The real hurdle is implementation Web editor Nicole Raleigh speaks with Andrew Stelzer, head of business development at Unlearn.AI, about effectively implementing AI.
Digital Patients as active consumers of care: AI-driven personalisat... In a new podcast, web editor Nicole Raleigh speaks with Bill Grambley, CEO of AllazoHealth, for a conversation on leveraging AI for marketing.
Digital GenAI and the revolution of drug development Bryan Hill, life sciences chief technology officer at Cognizant, discusses how generative AI is revolutionising drug development in a new podcast.
Digital Simulated clinical trial populations and AI scalability AI might still be in the modish buzzword stage, but discussions exploring the potential for its scaling within life sciences are critical.
Digital From science fiction to reality: AI in drug development In today’s pharmaphorum podcast, web editor Nicole Raleigh speaks with Dr Isaac Bentwich, CEO and founder of Quris.AI.
Digital Seeking effective, safe treatment for all with precision dos... Modern medicine moves ever more to precision, personalised medicine, and precision dosing is critical in a world that recognises biological individuality – especially when it comes to paedi
News Regeneron swoops on genetic testing firm 23andMe DNA testing company 23andMe looks destined to be taken over by a pharma company, as Regeneron agrees a $256 million acquisition deal.
Market Access Sponsored Bridging research and clinical guidelines – interactive stra... Medical affairs is evolving. Understanding how to harness real-world data and digital insights is essential.